Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipoproteinemia Type II

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

176 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Completed

Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

NCT00280995

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Chicago, Illinois, United States

New York, United States

Winston-Salem, North Carolina, United States

Cincinnati, Ohio, United States

View Trial Details

Completed

Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

NCT00281008

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Chicago, Illinois, United States

Auburn, Maine, United States

Scarborough, Maine, United States

New York, United States

View Trial Details

Completed

Postprandial Response After Intake of Meals With Different Fatty Acid Composition

NCT02729857

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations: University of Oslo Oslo, Post Box 1046, Blindern, Norway

View Trial Details

Completed

Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry

NCT02778646

Conditions: Cardiac Event, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Not specified

View Trial Details

Completed

Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia

NCT02462655

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Institute of Nutrition and Functional Foods (INAF) Québec, Quebec, Canada

View Trial Details

Completed

Hyperapo B and Coronary Heart Disease

NCT00005168

Conditions: Body Weight, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: Not specified

View Trial Details

Completed

A Pilot Study to Evaluate the Lipid Effects of TRIA-662

NCT02008084

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Crowfoot Village Family Practice Calgary, Alberta, Canada

Dr. Senaratne Professional Corporation Edmonton, Alberta, Canada

The Bailey Clinic Red Deer, Alberta, Canada

Manna Research Vancouver Vancouver, British Columbia, Canada

View all 17 locations

View Trial Details

Completed

Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia

NCT02100839

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Linear Clinical Research Ltd. Nedlands, Western Australia, Australia

View Trial Details

Completed

A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

NCT01012219

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter

NCT01753232

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more
Locations: Nierenzentrum Mannheim Mannheim, Baden Würtemberg, Germany

Medizinisches Versorgungszentrum Kempten (Allgäu), Bavaria, Germany

Universitätsklinikum Regensburg Institut für Klinische Chemie und Laboratoriumsmedizin Regensburg, Bavaria, Germany

Dialysezentrum Potsdam Potsdam, Brandenburg, Germany

View Trial Details